Axilur vet. 250 mg Tablett
Axilur vet. 250 mg Tablett
Authorised
- Fenbendazole
Product identification
Medicine name:
Axilur vet. 250 mg Tablett
Active substance:
- Fenbendazole
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Fenbendazole250.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC13
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Sweden
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Oriola Sweden AB
- Intervet Ges.m.b.H.
Responsible authority:
- Swedish Medical Products Agency
Authorisation number:
- 10776
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 26/04/2022
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Swedish (PDF)
Published on: 26/04/2022
How useful was this page?: